Adalta Ltd has released a press release.
AdAlta: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Quarterly Appendix 4C and Activities Report
- AdCella milestones and regulatory progress
- Placement raises A$1.2 million
- CAR-T collaboration agreement
- $0.78 million FY25 RDTI refund received
Later from AdAlta
- AdCella Clinical Advisory Board convened
- AdCella expands clinical advisory board
- New AD-214 patent granted
- AdCella and SHcell hold first JDC meeting
- BZDS1901 clinical update
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta